| License: Creative Commons Attribution 4.0 (5MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-355444
- DOI to cite this document:
- 10.5283/epub.35544
Abstract
Cancer immunotherapy has been shown to enhance established treatment regimens. We evaluated the potential reinforcing effect of IL-15 in trastuzumab treated humanized tumor mice (HTM) which were generated by concurrent transplantation of neonatal NOD-scid IL2R.null mice with human hematopoietic stem cells (HSC) and HER2 positive breast cancer cells (metastasizing SK-BR-3, solid tumor forming ...

Owner only: item control page